Literature DB >> 2957447

Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes.

M Capron, M D Kazatchkine, E Fischer, M Joseph, A E Butterworth, J P Kusnierz, L Prin, J P Papin, A Capron.   

Abstract

The participation of complement receptor type 3 (CR3) in antibody-dependent effector function of human eosinophils against parasites was studied by using monoclonal antibodies directed against various surface molecules. Both adherence and cytotoxicity of hypodense eosinophils to IgE-coated schistosomula of Schistosoma mansoni were strongly inhibited by anti-CR3 antibodies (OKM1 or Mo1). The specificity of the inhibitory effect for the alpha-chain of CR3 was shown by the lack of inhibition of anti-beta-chain or anti-LFA1 alpha-chain monoclonal antibodies, although these antigens were expressed on human eosinophils. These results associated to previous works on IgE receptors demonstrate that both receptor for Fc fragments of IgE and CR3 are essential in IgE-dependent cytotoxicity of human eosinophils. Flow microfluorometry analysis revealed that hypodense eosinophils were more intensively stained by OKM1 antibodies than the normodense populations. In the case of IgG-mediated cytotoxicity by normodense eosinophils, only the enhancement of cytotoxicity due to monokine activation was inhibited by anti-CR3 alpha-chain antibodies. These findings suggest an increased expression of CR3 on eosinophils after activation either in vivo or in vitro. The participation of CR3 in IgE-mediated cytotoxicity against schistosomes was also required in the case of blood monocytes but not for platelet-mediated killing, which does not require prior adherence. The biologic role of CR3 is therefore extended to effector mechanisms involving eosinophils and two different isotypes of antibodies and possibly implied in immunity against schistosomes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957447

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Characterization of liver lymphomyeloid cells in mice infected with Plasmodium yoelii sporozoites.

Authors:  P Faure; M Marussig; P Goossens; F Miltgen; D Mazier
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

3.  Expression of FCepsilonII/CD23 on human neutrophils isolated from rheumatoid arthritis patients.

Authors:  A Vella; P Bellavite; A Adami; R Ortolani; G Benoni; A Carletto; D Biasi; P Caramaschi; G Tridente
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

4.  Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro.

Authors:  M Feldmesser; A Casadevall; Y Kress; G Spira; A Orlofsky
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

5.  Cell-adhesion molecules expressed by activated eosinophils in Onchocerca volvulus infection.

Authors:  N W Brattig; A Z Abakar; F Geisinger; T F Kruppa
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

Review 6.  Eosinophil IgE receptor and CD23.

Authors:  M Capron; M J Truong; D Aldebert; V Gruart; M Suemura; G Delespesse; B Tourvieille; A Capron
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

7.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans.

Authors:  Lisa M Ganley-Leal; Pauline N Mwinzi; Catherine B Cetre-Sossah; Julius Andove; Allen W Hightower; Diana M S Karanja; Daniel G Colley; W Evan Secor
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.

Authors:  A Hartnell; A B Kay; A J Wardlaw
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

10.  Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes.

Authors:  J A Boyce; D Friend; M F Gurish; K F Austen; W F Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.